Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,623 | $2,401 | $2,861 | $7,483 |
| Short-Term Investments | $10,434 | $8,294 | $9,993 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $869 | $591 | $517 | $715 |
| Total Curr. Assets | $14,926 | $11,286 | $13,370 | $8,198 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $483 | $583 | $705 | $809 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $300 | $300 | $383 | $350 |
| Total NC Assets | $783 | $883 | $1,088 | $1,159 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $15,709 | $12,169 | $14,458 | $9,357 |
| Liabilities | – | – | – | – |
| Payables | $906 | $527 | $606 | $923 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $78 | $94 | $160 | $200 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,198 | $2,961 | $2,762 | $3,453 |
| Total Curr. Liab. | $4,181 | $3,581 | $3,528 | $4,576 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2,324 | $2,924 | $3,524 | $4,124 |
| Total NC Liab. | $2,324 | $2,924 | $3,524 | $4,124 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,505 | $6,505 | $7,051 | $8,700 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$55,166 | -$46,203 | -$37,517 | -$28,070 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $64,370 | $51,867 | $44,924 | $28,727 |
| Total Equity | $9,205 | $5,664 | $7,407 | $657 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $15,709 | $12,169 | $14,458 | $9,357 |
| Net Debt | -$3,623 | -$2,401 | -$2,861 | -$7,483 |